Date | Insider | Price | Amount |
---|---|---|---|
11-13-2023 Insider Buy |
Martin Edwards Director |
$20.54 CAGR » |
$48,803.04 2,376 shares |
11-13-2023 Insider Buy |
Joseph P. Slattery Director |
$20.60 CAGR » |
$49,435.68 2,400 shares |
5-3-2023 Insider Buy |
Timothy A. Springer Director and >10% Owner |
$45.00 CAGR » |
$47,250,000.00 1,050,000 shares |
5-21-2021 Insider Buy |
Timothy A. Springer Director and >10% Owner |
$45.50 CAGR » |
$10,569,422.50 232,295 shares |
5-26-2021 Insider Buy |
Timothy A. Springer Director and >10% Owner |
$46.28 CAGR » |
$6,015,992.41 130,000 shares |
5-21-2021 Insider Buy |
Timothy A. Springer Director and >10% Owner |
$45.50 CAGR » |
$10,569,422.50 232,295 shares |
3-5-2021 Insider Buy |
Vikas Goyal Director |
$70.00 CAGR » |
$70,000.00 1,000 shares |
3-5-2021 Insider Buy |
Timothy A. Springer Director and >10% Owner |
$70.00 CAGR » |
$7,000,000.00 100,000 shares |
6-28-2019 Insider Buy |
Holdings A/S Novo >10% Owner |
$15.00 CAGR » |
$10,000,005.00 666,667 shares |
7-1-2019 Insider Buy |
Plc Glaxosmithkline Director |
$15.00 CAGR » |
$4,999,995.00 333,333 shares |
7-1-2019 Insider Buy |
Omega Fund V, L.P. >10% Owner |
$15.00 CAGR » |
$1,999,995.00 133,333 shares |
7-1-2019 Insider Buy |
Otello Stampacchia Director and >10% Owner |
$15.00 CAGR » |
$1,999,995.00 133,333 shares |
7-1-2019 Insider Buy |
Timothy A. Springer Director and >10% Owner |
$15.00 CAGR » |
$499,995.00 33,333 shares |
7-1-2019 Insider Buy |
Vikas Goyal Director |
$15.00 CAGR » |
$4,999,995.00 333,333 shares |
Also See: Institutional Holders of MORF
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 11/14/2023 | |
End date: | 05/06/2024 | |
Start price/share: | $22.73 | |
End price/share: | $30.35 | |
Dividends collected/share: | $0.00 | |
Total return: | 33.52% | |
Annualized Gain: | 70.73% | |
Starting investment: | $10,000.00 | |
Ending investment: | $13,352.00 | |
Years: | 0.47 |
Morphic Holding Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Morphic Holding insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding MORF
Free MORF Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Morphic Holding Insider Buying occurred are:
Intellicheck Insider Buying |